Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid-responsive enteropathy of infancy.

Steven N Lichtman1, Katherine B Freeman, J Marc Rhoads

  • 1Department of Pediatrics, University of North Carolina at Chapel Hill, 27599-7220, USA. lichtman@med.unc.edu

Journal of Health, Population, and Nutrition
|April 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limosilactobacillus reuteri Strains Differentially Stimulate Immunity in Response to Human Milk Oligosaccharides in Newborn Mice.

Probiotics and antimicrobial proteins·2025
Same author

Reduced autoimmunity associated with deletion of host CD73.

ImmunoHorizons·2025
Same author

Probiotic <i>Limosilactobacillus reuteri</i> DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice.

Nutrients·2024
Same author

The many faces of microbiota-gut-brain axis in autism spectrum disorder.

Life sciences·2023
Same author

Probiotic-derived ecto-5'-nucleotidase produces anti-inflammatory adenosine metabolites in Treg-deficient scurfy mice.

Research square·2023
Same author

Columnar Metaplasia of the Esophagus Presenting as Iron Deficiency Anemia in Children with Neurologic Impairment or Congenital Esophageal Atresia.

The American journal of case reports·2022

Corticosteroids effectively treated persistent diarrhea in infants unresponsive to formula. This treatment offers rapid symptom resolution, suggesting its benefit for similar pediatric cases.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Immunology

Background:

  • Persistent diarrhea in infants under three months is a significant clinical challenge.
  • Infants presented with severe symptoms including acidosis, hypoalbuminemia, and malnutrition.
  • Standard formula treatments were ineffective in resolving the persistent diarrhea.

Purpose of the Study:

  • To evaluate the efficacy of intravenous corticosteroids in treating persistent diarrhea of unknown origin in infants.
  • To compare outcomes in infants treated with corticosteroids versus those who did not receive them.

Main Methods:

  • A cohort of 19 infants with persistent diarrhea, acidosis, hypoalbuminemia, and malnutrition was studied.
  • Endoscopic biopsies revealed gastrointestinal inflammation.

Related Experiment Videos

  • 14 infants received intravenous corticosteroids, while 5 served as a control group.

    • Main Results:

    • Infants treated with corticosteroids experienced rapid diarrhea resolution (3.8 days).
    • Controls had significantly prolonged diarrhea (92-147 days in 3 infants).
    • Corticosteroids were well-tolerated and successfully weaned over four months.

    Conclusions:

    • Intravenous corticosteroids are a beneficial treatment for infants with unresponsive persistent diarrhea of unknown origin.
    • The findings support prospective evaluation of corticosteroids for this condition.
    • Early intervention with corticosteroids may prevent prolonged illness and malnutrition in affected infants.